US$ 29.18
eli lilly semaglutide drug FDA Approves Weight Drug, Now Set to Compete Against Novo's Wegovy Eli Lilly launches its blockbuster
Description
Nature (1981) 289(5797):5146
It is FDA-approved for chronic weight management in adults with a BMI of 30 or higher, or 27 or higher with a weight-related condition, such as high blood pressure or diabetes

Ozempic side effects could lead to hospitalization and doctors warn that long-term impacts remain unknown

Remember, when it comes to medications like Semaglutide, it's always better to be safe than sorry

If coverage exists, the in-person route through a weight management program at IU Health or a private practice makes sense
Additionally, semaglutide for weight loss has gained significant attention
